Introduction {#sec1-1}
============

Dementia is a neurodegenerative disease that is linearly correlated with aging \[[@ref1]\]. The incidence is reduced by age below 60 years. Dementia is characterized by a decrease in cognitive and behavioral function. Dementia is also a marker of progressive destruction of the brain's physiological function, Alzheimer's is one of the most frightening forms of dementia, hence numerous studies have been conducted both in vivo and in vitro to know more about the pathological path of dementia so that scientists can know how to prevent and treat the condition.

Recent studies have shown a link between the incidence of diabetes mellitus (DM) \[[@ref2]\], \[[@ref3]\], \[[@ref4]\] and an increased risk factor for the occurrence of dementia. Dementia in diabetic patients is associated with an impairment of brain insulin receptors leading to a decrease in cognitive function (learning and remembering) and behavioral alterations presumably caused by cerebral inflammation \[[@ref5]\], \[[@ref6]\], \[[@ref7]\].

Cucumber plant (*Mikania micrantha K*), which is a plant of the genus Asteracea, which until now only 42 species of plant families have been experiments on biological activity. Where the plant has anti-inflammatory, analgesic, anti-bacterial, anti-protozoa, antioxidant and cytotoxic. Recent research also mentions that mikania micrantha cultivation can be used for depression conditions. Therefore, in this study, we will conduct an investigation of anti-dementia activity test from mikania plant to animal model of diabetes mellitus which in induction alloxan.

Material and Methods {#sec1-2}
====================

Material {#sec2-1}
--------

Mikania micrantha, EtOH, Butanol, Ethyl Acetate, radial arm maze (RAM) \[[@ref8]\] Gluco D®, rotary evaporator, analytic balance, alloxan, aquadest, glibenclamide.

Animal {#sec2-2}
------

The test animals used were white male mice of 2-3 months *Mus musculus* strain which was fed and drank well before testing of the test animal was fasted for 18 hours.

Methods {#sec2-3}
-------

The dementia model was prepared by alloxan induction of 150 mg/kg i.p, in which all test animals showed a decreased cognitive ability to remember in the RAM test apparatus. During the acclimatization of the test animals, first use the cognition test tool using RAM \[[@ref9]\], \[[@ref8]\], \[[@ref10]\]. The animal group was divided into 6 test groups, comprising Positive group (glibenclamide), Negative group (alloxan induction) 150 mg/Kg BW.

The extracted group and 3 fractions (ethyl acetate, butane, and hexane) dose 500 mg/kg p.o given for 28 days. And observations of blood glucose and cognitive changes in the tool RAM performed on days 7, 14, 21 and 28

Results {#sec1-3}
=======

Observations during the test period showed a decrease in the blood glucose of test animals showed in [Table 1](#T1){ref-type="table"}.

###### 

Glucose blood level

  Group             1              7              14            21             28
  ----------------- -------------- -------------- ------------- -------------- -------------
  Positive          142.2 ± 8.5    103.6 ± 5.4    104.2 ± 5.2   115 ± 4.4      99 ± 4.6
  Negative          383.8 ± 10.1   334.2 ± 12.7   279.6 ± 9.0   239.6 ± 10.3   240.2 ± 6.3
  Extract           241.4 ± 4.7    200.2 ± 3.2    176.6 ± 2.7   137.6 ± 7.9    133.8 ± 5.7
  f-ethyl acetate   234 ± 3.6      185.2 ± 3.6    161 ± 2.9     141 ± 7.4      123.8 ± 3.6
  f-butane          250.2 ± 4.7    208 ± 6.7      179.8 ± 4.2   156.8 ± 4.0    160.6 ± 7.0
  f-hexane          276 ± 6.8      220.6 ± 3.4    204.4 ± 3.9   186 ± 4.7      171.2 ± 3.0

The results of decreased blood glucose of the test animals during the observation period showed that during the testing period the ethyl acetate fraction gave significant glucose decrease compared with the positive control (glibenclamide); All value is mean ± standard error (n = 6); Statistical analysis with LSD (\*P \< 0.05).

[Table 1](#T1){ref-type="table"} showed that From this study it is known that the use of alloxan as an inducer of blood glucose increase is quite good in showing the increase of blood glucose as a manifestation of type 2 diabetes mellitus this is shown at the level of blood glucose in the negative group (alloxan induction) gives a significant increase in blood glucose up to the day to 28. The test group using the mikania sp fraction which gave the best glucose reduction in the test animals was from the ethyl acetate fraction group. However, the decrease in glucose levels by ethyl acetate fraction has not been as good as the decrease of glucose level by glibenclamide group.

The increase of blood glucose by induced by alloxan is good enough to provide a model of dementia in test animals where increased glucose in the blood leads to increased time required for test animals to complete their tests on the RAM device. Giving a fraction of the Mikania Sp plant from the ethyl acetate fraction provides a memory improvement performance which is indicated by the decrease of time required by the test animal completing its task on the RAM tool. This was demonstrated by no significant difference in the performance of test animals on RAM devices between ethyl acetate fraction groups and glibenclamide group be seen in the [Table 2](#T2){ref-type="table"}.

###### 

Retention Time on RAM

  Group             1              7             14            21            28
  ----------------- -------------- ------------- ------------- ------------- -------------
  Positive          297.2 ± 1.35   233.4 ± 1.7   190 ± 1.4     183 ± 1.0     171.8 ± 1.2
  Negative          600 ± 0        460.4 ± 2.3   429.8 ± 1.8   419.6 ± 0.9   402.8 ± 1.7
  Extract           288.2 ± 1.4    272.4 ± 1.8   217.8 ± 1.4   188.4 ± 1.3   169.4 ± 1.0
  f ethyl acetate   297 ± 1.7      244.4 ± 1.3   216.6 ± 1.3   195 ± 1.4     171 ± 1.7
  f-butanol         309.8 ± 1.3    265.4 ± 1.6   223.4 ± 1.6   203.4 ± 1.3   192.2 ± 1.3
  f-hexane          316.4 ± 1.1    306.6 ± 2.9   290.2 ± 1.4   241 ± 1.4     204.8 ± 1.2

The results of retention time on RAM showed that during the testing period the ethyl acetate fraction gave significant decrease time on RAM compared with the positive control (glibenclamide); All value is mean ± standard error (n = 6); Statistical analysis with LSD (\*P \< 0.05).

A similar thing is seen at the level of animal testing error when completing the task on the RAM tool. Groups of ethyl acetate fraction and Mikania extract Sp gave fewer mistakes similar to those given by the glibenclamide group. This was demonstrated by no significant difference in the performance of test animals on RAM devices between ethyl acetate fraction groups and glibenclamide group be seen in the [Table 3](#T3){ref-type="table"}.

###### 

Error Choice of RAM

  Group             1           7           14          21          28
  ----------------- ----------- ----------- ----------- ----------- -----------
  Positif           6.2 ± 0.2   3.4 ± 0.2   4 ± 0.4     2.6 ± 0.2   2.4 ± 0.2
  Negative          0           7.7 ± 0.5   7.8 ± 0.3   7.4 ± 0.5   7.2 ± 0.3
  Extract           6 ± 0.4     3.6 ± 0.2   3 ± 0.3     2.4 ± 0.3   2.2 ± 0.2
  f ethyl acetate   4.8 ± 0.3   4 ± 0.4     3.4 ± 0.2   3.2 ± 0.3   2.6 ± 0.4
  f-butanol         6.4 ± 0.5   4.4 ± 0.2   3.8 ± 0.3   3.4 ± 0.4   2.8 ± 0.3
  f-hexane          7.8 ± 0.3   4.6 ± 0.4   4 ± 0.3     3.8 ± 0.3   3 ± 0.4

The results of Error choice on RAM showed that during the testing period the ethyl acetate fraction gave significant low error choice on RAM compared with the positive control (glibenclamide); All value is mean ± standard error (n = 6); Statistical analysis with LSD (\*P \<0.05).

Discussion {#sec1-4}
==========

To see the impact of memory performance improvements on our RAM tools make animal models of dementia by using alloxan induction. in some previous journals have also mentioned that the rise in blood glucose, especially in diabetic patients believed to have a significant impact on the formation of dementia in correlation with cerebral vascular inflammation resulting in decreased cognitive abilities and behavioral changes of diabetic patients. cognitive decline, especially in the ability to learn and remember this is due to a decrease in sensitivity to insulin signals in the brain. vascular inflammatory conditions and beta-amyloid plaque formation are believed to be closely related to the progress of the severity of Alzheimer's disease \[[@ref2]\], \[[@ref3]\], \[[@ref11]\].

In this study showed that dementia animal model can be generated by alloxan induction, in which the increase of blood glucose in animal test resulted in the decrease of blood glucose level from all animal group of tests and decrease of blood glucose seen significantly in ethyl acetate group compared with group glibenclamide as a positive group. compound compounds in plants that have anti-diabetic activity are believed to be from terpenoid group compounds that can reduce the damaging effects of excessive oxidation on pancreatic beta cells in this case as a result of alloxan induction. as a result of decreased oxidation reaction by this terpenoid, group compound showed improvement of blood glucose levels. the in vivo study of the Mikania micrantha plant showed that this plant had 13 identifiable sesquiterpen lactones compounds. micrantholides are thought to have excellent anti-inflammatory properties. triterpenes and phytosterols are known to be widespread in plants from the Mikania family \[[@ref12]\], \[[@ref13]\], \[[@ref14]\].

Improvements in memory performance in RAM assayers showed significance in the ethyl acetate group of animals compared with the negative group and positive group by decreasing retention time and many faults from the test animals to find their food in the RAM device. when compared with the positive test animal group (glibenclamide), the ethyl acetate assay group gave significant improvement in memory performance in follow-up with the extract group. this reinforces the notion that the chemical compounds of the mikania plant of the ethyl acetate fraction have activity against the memory improvement of the test animals. Because the dementia model derived from alloxan induction this can reinforce the theory that diabetes is a risk factor of the incidence of dementia. Dementia as a pointer to the progressive destruction of nerve cell cells where the worst effects of dementia conditions are Alzheimer's disease that remains unaccounted for. however, the memory repair mechanism of the Mikania micrantha compound on memory improvement is still unclear, whether this memory repair works directly on the improvement of insulin signaling in the brain that will inhibit inflammation in the brain that can improve cognitive performance \[[@ref2]\], \[[@ref15]\], \[[@ref13]\], \[[@ref4]\] animal approach of this animal model of diabetes can be used as a preliminary study in studying the course of the disease from dementia. from the results obtained further research led the researcher to be able to continue to elude other dementia models to find a suitable mechanism to explain the pathological condition of dementia in order to lead to the discovery of compounds that can be used as neuro-protection and neuro-curative useful for further treatment \[[@ref16]\], \[[@ref17]\], \[[@ref18]\], \[[@ref8]\], \[[@ref19]\].

In conclusion from the results of this study showed that *Mikania micrantha* has a positive activity on the central nervous system and can be used as an alternative plant as neuro-protection and neuro-curative.

We would like to thank the Herbarium Laboratory of Plant Taxonomy Department of Biology FMIPA UNPAD which has issued the result of plant determination.

**Funding:** This research did not receive any financial support

**Competing Interests:** The authors have declared that no competing interests exist
